Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers

被引：0
作者：
Peiyi Xia
Lan Zhang
Pan Li
Enjie Liu
Wencai Li
Jianying Zhang
Hui Li
Xiaoxing Su
Guozhong Jiang
机构：
[1] The First Affiliated Hospital of Zhengzhou University,Department of Pathology
[2] Zhengzhou University,Institute of Medical and Pharmaceutical Sciences
[3] Zhengzhou University,Clinical Research Division
[4] Berry Oncology Corporation,undefined
来源：
Journal of Translational Medicine | / 19卷
关键词：
fusion; Complex rearrangements; Non-small cell lung cancer; Next-generation sequencing; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 281 条
  • [1] Lin JJ(2017)Targeting ALK: precision medicine takes on drug resistance Cancer Discov 7 137-155
  • [2] Riely GJ(2018)Impact of EML4-ALK variant on resistance mechanisms and clinical outcomes in ALK-positive lung cancer J Clin Oncol 36 1199-1206
  • [3] Shaw AT(2010)Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 1693-1703
  • [4] Lin JJ(2013)Crizotinib versus chemotherapy in advanced ALK-positive lung cancer N Engl J Med 368 2385-2394
  • [5] Zhu VW(2013)CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study Lancet Oncol 14 590-598
  • [6] Yoda S(2016)Alectinib in crizotinib-refractory ALK-rearranged non-small-cell lung cancer: a Phase II Global Study J Clin Oncol 34 661-668
  • [7] Yeap BY(2016)Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial Lancet Oncol 17 234-242
  • [8] Schrock AB(2014)Ceritinib in ALK-rearranged non-small-cell lung cancer N Engl J Med 370 1189-1197
  • [9] Dagogo-Jack I(2016)Activity and safety of ceritinib in patients with ALK -rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial Lancet Oncol 17 452-463
  • [10] Jessop NA(2015)Alternative transcription initiation leads to expression of a novel ALK isoform in cancer Nature 526 453-457
12345678910